June 16, 2016

Electronic Glycemic Management System Reduces Hypoglycemic Event Rate

Hypoglycemic events are less likely in inpatients with diabetes treated with an electronic glycemic management system compared with usual care, according to data presented here.

“Patients who were treated with the [electronic glycemic management system] had a statistically lower incidence of hypoglycemic events and lower average blood glucose compared with [usual care], suggesting it may be easier to achieve glycemic targets safely for patient in the hospital setting,” Joseph Aloi, MD, section chief of endocrinology and metabolism at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina, told Endocrine Today.

Glytec’s Glucommander and eGlycemic Management System Featured in Five Studies Presented at The American Diabetes Association’s 76th Scientific Sessions

Wide range of studies further demonstrates significant impact in the emergency department, hospital and outpatient settings.

Glytec, the pioneer and leader in providing innovative, FDA-cleared glucose management software solutions, today announced that the company has presented five abstracts addressing a range of issues related to diabetes care at the American Diabetes Association’s 76th Scientific Sessions in New Orleans, Louisiana, June 10-14, 2016. The American Diabetes Association (ADA) brings together global leaders to discuss advancements in diabetes research and care.

June 5, 2016

Glucommander Linked to Improved Blood Glucose Levels

The inclusion of a computer-guided program (Glucommander) as a component of diabetic ketoacidosis management was associated with significantly less hypoglycemia and faster time to normalization of blood glucose and bicarbonate than standard treatment of diabetic ketoacidosis, according to a new retrospective multicenter study.

The data were presented at the American Association of Clinical Endocrinologists (AACE) 25th Annual Scientific & Clinical Congress. The study also demonstrated a significant difference in length of hospital stay for patients treated with Glucommander compared with standard protocol (3.2 vs 4.5 days).

June 1, 2016

Glytec Presents Key Studies at the AACE 25th Annual Scientific and Clinical Congress

Experts demonstrate the ability of automated glucose management to significantly reduce rates of hypoglycemia and DKA.

Glytec, the pioneer and leader in providing innovative, FDA cleared glucose management software solutions, today announced that two abstracts addressing the approach to care for patients suffering from hypoglycemia and diabetic ketoacidosis (DKA) were presented at the American Association of Clinical Endocrinologists (AACE) 25th Annual Scientific and Clinical Congress, held from May 25-29th in Orlando, Florida.

May 31, 2016

Computer Algorithms Managing Insulin Dosages Result in Better Glycemic Control

When insulin dosages are calculated using computer algorithms to reach target blood glucose levels, hospitalized patients are less likely to have episodes of low blood sugar and recover sooner from diabetic ketoacidosis than when insulin dosages are calculated without an algorithm.

Those were key findings from two multisite studies presented at the American Association of Clinical Endocrinologists meeting, held May 25-29 in Orlando, Florida. “Computer algorithms facilitate doing the right thing,” said Dr. Joseph A. Aloi, professor of endocrinology and metabolism at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina, and the studies’ principal investigator.

June 8, 2015

Glytec Presents Several Research Studies at the ADA 75th Scientific Sessions

Data continue to validate the benefits of standardized glycemic management through computerized decision support for both IV and subcutaneous insulin dosing.

Glytec, the pioneer and leader in providing innovative, FDA-cleared glucose management software solutions central to effective diabetes management, today announced that several abstracts featuring the company’s eGlycemic Management Solution® (eGMS®) have been selected as poster presentations at the American Diabetes Association 75th Scientific Sessions. The 75th Scientific Sessions, taking place from June 5-9th in Boston, are the premier venue for exchanging news and showcasing innovation to the diabetes community.

May 19, 2015

Glytec Presents Several Research Studies at the AACE 24th Annual Scientific and Clinical Congress

Leading industry experts present the benefits of automated glucose management for both IV and subcutaneous insulin dosing.

Glytec, the pioneer and leader in providing innovative glucose management software solutions central to effective diabetes management, today announced that several abstracts featuring the company’s eGlycemic Management System® (eGMS®) were selected as poster presentations at the American Association of Clinical Endocrinologists (AACE) 24th Annual Scientific and Clinical Congress, which took place from May 13-17th in Nashville, Tennessee.

May 7, 2015

Studies Provide Additional Validation of the Benefits of Automated Glucose Management for Both IV and SubQ Insulin Dosing

Wide range of studies further demonstrates significant impact in the emergency department, hospital and outpatient settings.

Glytec, the pioneer and leader in providing innovative, FDA-cleared glucose management software solutions central to effective diabetes management, today announced that several abstracts featuring the company’s eGlycemic Management Solution® (eGMS®) have been selected as poster presentations at the International Hospital Diabetes Meeting (IHDM), taking place from May 8-9th in San Francisco. Hosted by the Diabetes Technology Society, the fifth annual IHDM conference will showcase the optimal use of future and current technologies for people with diabetes in both critical and non-critical care settings.

June 12, 2014

New Data About Inpatient Blood Sugar Management to Be Revealed at American Diabetes Association Meeting

During the conference, several posters will be presented that highlight the success of improved glycemic management achieved by healthcare providers utilizing Glytec’s eGMS®.

Glytec, a clinical information technology company solely dedicated to the mission of improving insulin management and glycemic control, today announced that several abstracts featuring the company’s eGlycemic Management System® (eGMS®) have been selected as poster presentations at the American Diabetes Association (ADA) 74th Scientific Sessions. The 74th Scientific Sessions, taking place from June 13th to June 17th in San Francisco, are the premier venue for exchanging news and showcasing innovation to the diabetes community.

May 16, 2014

E-Check of Sugar Aids in Inpatient Hypoglycemia Control

Electronic monitoring of blood sugar levels may diminish hypoglycemia and reduce length of stay in hospitalized diabetic ketoacidosis (DKA) patients, researchers reported here.

In one study, patients monitored with the Glucommander system reduced episodes of hypoglycemia by 56%, Joseph Aloi, MD, director of the Strelitz Diabetes Center at Eastern Virginia Medical School in Norfolk, and colleagues reported at the American Association of Clinical Endocrinologists meeting here. In a second study, they showed that the same system reduced the overall hospital length of stay by nearly 2 1/2 days in patients with diabetic ketoacidosis.

May 13, 2014

Glytec Announces Late Breaking Abstracts Accepted for Poster Presentations at American Association of Clinical Endocrinologists 23rd Annual Scientific & Clinical Congress

Conducted by researchers from Duke University School of Nursing, Piedmont Healthcare, Jackson Madison County General Hospital, Sentara Health System and Eastern Virginia Medical School, the poster presentations will highlight research results evaluating Glytec’s eGlycemic Management System® in three leading acute care hospitals.

Glytec, LLC, a clinical information technology company dedicated to the mission of improving insulin management and glycemic control, announced today that several late breaking abstracts featuring the company’s eGlycemic Management System have been accepted for poster presentations at the American Association of Clinical Endocrinologists 23rd Annual Scientific and Clinical Congress, taking place from May 14 – May 18, 2014, in Las Vegas. The posters will be displayed from 9:30 a.m. to 1:00 p.m. on Saturday, May 17th in the General Poster Sessions in the exhibit hall. Presentations by the lead authors will occur from 9:45 a.m. to 11:00 a.m. on Saturday, May 17th.

Eastern Virginia Medical School Study Indicates Major Glycemic Improvement in Subcutaneous Basal Bolus Insulin Delivery Using eGlycemic Management System

Poster presented during AACE shows improved outcomes using Glytec’s subcutaneous insulin dosing solution versus traditional basal bolus insulin therapy.

Glytec, a clinical information technology company solely dedicated to the mission of improving insulin management and glycemic control, is pleased to share the results of a late-breaking poster that was presented at the American Association of Clinical Endocrinologists (AACE) 23rd Annual Scientific and Clinical Congress. The poster is based on results experienced by Sentara Healthcare during the first 30 days after using Glytec’s Glucommander™ SubQ to manage subcutaneous Basal Bolus Insulin (BBI) therapy. The poster was presented by Joseph Aloi, MD, clinical director of the Strelitz Diabetes Center at Eastern Virginia Medical School, during the Congress’s general poster session.

September 19, 2011

GlucoTec, Inc. Completes Series A Preferred Stock Financing

Glytec will use the capital primarily to expand its direct US sales force, increase its international presence and advance research and development.

GlucoTec, Inc., the privately-held parent company of Glytec, LLC, today announced that it has completed a Series A Preferred Stock financing totaling $8,273,078.

March 7, 2011

West Tennessee Healthcare Accelerates Optimum Inpatient Glucose Control with Glucommander Plus

The Glucommander Plus software provides healthcare professionals with individualized insulin dosing requirements for hospitalized patients.

Dave Roberts, MD, Vice President and Chief Medical Officer at West Tennessee Healthcare recently conducted a webinar presenting a systems approach to inpatient glucose control using the Glucommander Plus software from Glytec. The software includes many safety guardrails including predictive warning and alerts, a fully-integrated and real-time reporting engine, and precision bolus dosing of meal-time insulin.

June 28, 2010

Computerized Algorithm Can Enable Tight Glycemic Control

The Glucommander computerized intravenous insulin controller (CIIC) for insulin dosing enables providers to avoid hypoglycemia by accurately controlling patients’ blood glucose to desired target levels.

What if your facility could safely and effectively achieve tight glycemic control among patients in the intensive care unit (ICU) with little danger of severe hypoglycemia? According to study results presented at the American Diabetes Association 70th Scientific Sessions, this outcome is possible through the use of Glucommander, a computerized algorithm that accurately manages intravenous insulin.